scispace - formally typeset
A

Anand Swaroop

Researcher at National Institutes of Health

Publications -  528
Citations -  53580

Anand Swaroop is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Retinitis pigmentosa & Retinal degeneration. The author has an hindex of 89, co-authored 508 publications receiving 43170 citations. Previous affiliations of Anand Swaroop include Vision-Sciences, Inc. & Yale University.

Papers
More filters
Posted ContentDOI

Deep-learning-based Prediction of Late Age-Related Macular Degeneration Progression

TL;DR: The results showed that the color fundus photos coupled with genotypes could predict late AMD progression with an averaged area under the curve (AUC) value of 0.85, and the model was implemented in a cloud-based application for individual risk assessment.
Journal ArticleDOI

A novel protodioscin-enriched fenugreek seed extract (Trigonella foenum-graecum, family Fabaceae) improves free testosterone level and sperm profile in healthy volunteers

TL;DR: Results confirmed that this protodioscin-enriched extract from fenugreek seeds (Furosap) is safe and efficacious in boosting serum free testosterone levels, healthy sperm profile, mental alertness, cardiovascular health, and overall performance in male volunteers.
Journal ArticleDOI

What's in a Name? RPGR Mutations Redefine the Genetic and Phenotypic Landscape in Retinal Degenerative Diseases

TL;DR: Findings have significant clinical implications as RPGR now occupies a prominent causative role in inherited retinopathies, exhibiting divergent clinical phenotypes and genetic spectrum and when providing genetic diagnosis and counseling to patients with retinal dystrophies, RPGR screening should receive serious consideration.
Journal ArticleDOI

Genetics and therapy for pediatric eye diseases.

TL;DR: This review summarizes recent advances in understanding of early-onset ocular disorders and highlights genetic complexities in development and diseases, specifically focusing on coloboma, congenital glaucoma and Leber congenital amaurosis.
Journal ArticleDOI

Nicotinamide Promotes Formation of Retinal Organoids From Human Pluripotent Stem Cells via Enhanced Neural Cell Fate Commitment

TL;DR: It is reported here that early nicotinamide (NAM) treatment significantly improves RO yield across 8 hPSC lines from different donors, including some that would otherwise fail to generate a meaningful number of ROs.